The New Treatment Of Immune Thrombocytopenic Purpura
Primary immune thrombocytopenia (ITP) is an acquired immune mediated disorder characterized by isolated thrombocytopenia, defined as a peripheral blood platelet count less than 150 x 109/L, and the absence of any underiying cause. In Europe, adult ITP has an incidence of 1.6 to 3.9 cases per 100.000...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book Section PeerReviewed |
| Language: | English English |
| Published: |
Departemen Ilmu Penyakit Dalam Fakultas Kedokteran UNAIR
2014
|
| Subjects: | |
| Online Access: | http://repository.unair.ac.id/96208/1/The%20New%20Treatment%20of%20Immune.pdf http://repository.unair.ac.id/96208/2/Artikel%20The%20New%20Treatment%20of%20Immune_compressed.pdf http://repository.unair.ac.id/96208/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Universitas Airlangga |
| Language: | English English |
| Summary: | Primary immune thrombocytopenia (ITP) is an acquired immune mediated disorder characterized by isolated thrombocytopenia, defined as a peripheral blood platelet count less than 150 x 109/L, and the absence of any underiying cause. In Europe, adult ITP has an incidence of 1.6 to 3.9 cases per 100.000 per year with increasing incidence with older age and equal for the sexes except in the mid-adult years (30-60 years), when the disease is more prevalent in women. |
|---|